CombiMatrix Corp CBMX Financial and Strategic SWOT Analysis Review [Report Updated: 12072017] Prices from USD $125

07:33 EDT 31 Jul 2017 | BioPortfolio Reports

CombiMatrix Corp CBMX Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.
Corporate strategy Analyst's summarization of the company's business strategy.
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


CombiMatrix Corp CombiMatrix is a provider of molecular diagnostic solutions specializing in cytogenomic testing for prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. It offers DNAbased testing services for the detection of genetic abnormalities. The company provides chromosomal microarray, standardized and customized fluorescence in situ hybridization FISH and highresolution karyotyping. It provides these molecular diagnostic tests based on its array based technologies including Micro Arrays with single nucleotide polymorphism SNPs and Micro Arrays with SNPs for formalinfixed, paraffinembedded FFPE tissue. CombiMatrix is a CAP approved and CLIAcertified molecular diagnostic laboratory. CombiMatrix is headquartered in Irvine, California, the US.

CombiMatrix Corp Key Recent Developments

May 04,2017: CombiMatrix Reports First Quarter 2017 Financial and Operating Results
Mar 01,2017: CombiMatrix Appoints Molecular Diagnostics Veteran Dirk van den Boom, Ph.D. to its Board of Directors
Feb 22,2017: CombiMatrix Reports 2016 Fourth Quarter and Full Year Financial and Operating Results
Feb 02,2017: CombiMatrix Appoints Preeminent Pediatric Neurologist Dr. James W. Wheless to its Scientific Advisory Board
Jan 20,2017: CombiMatrix to Present LargeScale Study Indicating the Severity of Genomic Abnormalities Decreases from Conception to Childhood at the 2nd Congress on Recurrent Pregnancy Loss

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: CombiMatrix Corp CBMX Financial and Strategic SWOT Analysis Review [Report Updated: 12072017] Prices from USD $125


More From BioPortfolio on "CombiMatrix Corp CBMX Financial and Strategic SWOT Analysis Review [Report Updated: 12072017] Prices from USD $125"

Quick Search

Relevant Topics

Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

DNA Microarray
A DNA microarray or biochip is a collection of microscopic DNA spots attached to a solid surface used to measure the expression levels of large numbers of genes simultaneously or to genotype multiple regions of a genome.